Total Payments
$22,675
2024 Payments
$8,684
Companies
9
Transactions
28
Medicare Patients
663
Medicare Billing
$132,671
Payment Breakdown by Category
Consulting$14,935 (65.9%)
Other$4,200 (18.5%)
Travel$2,880 (12.7%)
Food & Beverage$659.29 (2.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $14,935 | 7 | 65.9% |
| Honoraria | $4,200 | 1 | 18.5% |
| Travel and Lodging | $2,880 | 9 | 12.7% |
| Food and Beverage | $659.29 | 11 | 2.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $11,224 | 12 | $0 (2024) |
| ARRAY BIOPHARMA INC | $4,200 | 1 | $0 (2021) |
| AbbVie, Inc. | $3,465 | 7 | $0 (2017) |
| BeiGene, Ltd. | $1,950 | 1 | $0 (2021) |
| Janssen Research & Development, LLC | $1,027 | 2 | $0 (2017) |
| Daiichi Sankyo Inc. | $525.00 | 1 | $0 (2024) |
| Lexicon Pharmaceuticals, Inc. | $178.95 | 2 | $0 (2020) |
| Merck Sharp & Dohme Corporation | $53.79 | 1 | $0 (2017) |
| Ipsen Biopharmaceuticals, Inc | $50.00 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $8,684 | 9 | AstraZeneca Pharmaceuticals LP ($8,159) |
| 2021 | $6,150 | 2 | ARRAY BIOPHARMA INC ($4,200) |
| 2020 | $178.95 | 2 | Lexicon Pharmaceuticals, Inc. ($178.95) |
| 2019 | $50.00 | 1 | Ipsen Biopharmaceuticals, Inc ($50.00) |
| 2017 | $7,611 | 14 | AbbVie, Inc. ($3,465) |
All Payment Transactions
28 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/07/2024 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $3,690.00 | General |
| 11/05/2024 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $2,870.00 | General |
| 11/04/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Travel and Lodging | In-kind items and services | $416.99 | General |
| Category: Oncology | ||||||
| 11/04/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Travel and Lodging | In-kind items and services | $336.55 | General |
| Category: Oncology | ||||||
| 11/04/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Food and Beverage | Cash or cash equivalent | $42.18 | General |
| Category: Oncology | ||||||
| 11/02/2024 | Daiichi Sankyo Inc. | ENHERTU (Drug) | Consulting Fee | Cash or cash equivalent | $525.00 | General |
| Category: ONCOLOGY | ||||||
| 11/02/2024 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Travel and Lodging | In-kind items and services | $416.99 | General |
| Category: Oncology | ||||||
| 11/02/2024 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Travel and Lodging | In-kind items and services | $336.55 | General |
| Category: Oncology | ||||||
| 11/02/2024 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $50.07 | General |
| Category: Oncology | ||||||
| 11/05/2021 | ARRAY BIOPHARMA INC | BRAFTOVI (Drug) | Honoraria | Cash or cash equivalent | $4,200.00 | General |
| Category: ONCOLOGY | ||||||
| 06/29/2021 | BeiGene, Ltd. | — | Consulting Fee | Cash or cash equivalent | $1,950.00 | General |
| 01/23/2020 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $124.60 | General |
| 01/23/2020 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $54.35 | General |
| 11/05/2019 | Ipsen Biopharmaceuticals, Inc | — | Consulting Fee | Cash or cash equivalent | $50.00 | General |
| 11/30/2017 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Consulting Fee | Cash or cash equivalent | $2,700.00 | General |
| Category: Oncology | ||||||
| 11/16/2017 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Travel and Lodging | In-kind items and services | $163.71 | General |
| Category: Oncology | ||||||
| 11/16/2017 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $76.30 | General |
| Category: Oncology | ||||||
| 11/09/2017 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $53.79 | General |
| Category: ONCOLOGY | ||||||
| 06/03/2017 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $125.00 | General |
| 04/11/2017 | AbbVie, Inc. | — | Travel and Lodging | In-kind items and services | $157.29 | General |
| 04/11/2017 | AbbVie, Inc. | — | Travel and Lodging | In-kind items and services | $25.00 | General |
| 04/10/2017 | AbbVie, Inc. | — | Consulting Fee | Cash or cash equivalent | $3,150.00 | General |
| 03/31/2017 | AbbVie, Inc. | — | Food and Beverage | In-kind items and services | $60.00 | General |
| 03/31/2017 | AbbVie, Inc. | — | Food and Beverage | In-kind items and services | $33.00 | General |
| 03/31/2017 | AbbVie, Inc. | — | Food and Beverage | In-kind items and services | $20.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 197 | 370 | $108,093 | $35,427 |
| 2022 | 4 | 177 | 337 | $104,460 | $35,658 |
| 2021 | 5 | 165 | 334 | $101,768 | $34,880 |
| 2020 | 3 | 124 | 328 | $95,594 | $26,705 |
Total Patients
663
Total Services
1,369
Medicare Billing
$132,671
Procedure Codes
17
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 72 | 193 | $57,711 | $20,032 | 34.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 76 | 128 | $27,104 | $9,228 | 34.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 25 | 25 | $13,115 | $3,324 | 25.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 13 | 13 | $6,071 | $1,740 | 28.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 11 | 11 | $4,092 | $1,104 | 27.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 79 | 205 | $62,592 | $22,460 | 35.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 50 | 81 | $18,225 | $5,820 | 31.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 30 | 30 | $13,914 | $4,171 | 30.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 18 | 21 | $9,729 | $3,207 | 33.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 60 | 190 | $57,950 | $20,568 | 35.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 43 | 75 | $16,875 | $5,458 | 32.3% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 35 | 35 | $15,385 | $5,013 | 32.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 16 | 16 | $7,472 | $2,465 | 33.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 11 | 18 | $4,086 | $1,376 | 33.7% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 63 | 227 | $69,235 | $19,540 | 28.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 44 | 84 | $18,900 | $4,991 | 26.4% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Facility | 2020 | 17 | 17 | $7,459 | $2,174 | 29.2% |
About Zhonglin Hao, MD, PHD
Zhonglin Hao, MD, PHD is a Hematology & Oncology healthcare provider based in Lexington, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/17/2008. The National Provider Identifier (NPI) number assigned to this provider is 1356527543.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Zhonglin Hao, MD, PHD has received a total of $22,675 in payments from pharmaceutical and medical device companies, with $8,684 received in 2024. These payments were reported across 28 transactions from 9 companies. The most common payment nature is "Consulting Fee" ($14,935).
As a Medicare-enrolled provider, Hao has provided services to 663 Medicare beneficiaries, totaling 1,369 services with total Medicare billing of $132,671. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Other Specialties Internal Medicine, Medical Oncology
- Location Lexington, KY
- Active Since 01/17/2008
- Last Updated 12/06/2017
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1356527543
Products in Payments
- BRAFTOVI (Drug) $4,200
- TAGRISSO (Drug) $3,744
- IMFINZI (Biological) $795.72
- ENHERTU (Drug) $525.00
- KEYTRUDA (Biological) $53.79
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Lexington
Dr. Nicola Jabbour, M.d, M.D
Hematology & Oncology — Payments: $611,455
Hematology & Oncology $611,455
Dr. Lowell Anthony, M.d, M.D
Hematology & Oncology — Payments: $64,060
Hematology & Oncology $64,060
John Villano
Hematology & Oncology — Payments: $17,051
Hematology & Oncology $17,051
Dr. Jessica Croley, Md, MD
Hematology & Oncology — Payments: $13,189
Hematology & Oncology $13,189
Mr. Russell Eldridge, Md, MD
Hematology & Oncology — Payments: $10,781
Hematology & Oncology $10,781
Reinhold Munker
Hematology & Oncology — Payments: $9,229
Hematology & Oncology $9,229